AIXC — Aixcrypto Holdings Share News
0.000.00%
Last trade - 00:00Brief: Qualigen Therapeutics Announces Pre-IND Feedback From U.S. Food And Drug Administration Regarding QN-302 For The Treatment Of G4-Targeted Advanced Solid Tumors
U.S. STOCKS ON THE MOVE-Caterpillar, Coinbase, WW International
Qualigen Therapeutics down after reverse stock split plan
Brief: Qualigen Therapeutics Announces 1-For-10 Reverse Stock Split
Qualigen Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Qualigen Therapeutics Reports Q3 Financial Results And Provides Corporate Update
Qualigen Therapeutics Inc expected to post a loss of 13 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Kohl, Okta, Nano Labs
U.S. STOCKS ON THE MOVE-Farmer Bros, gold miners, U.S. banks
Qualigen gains on extension of deadline to meet Nasdaq listing norms
Brief: Qualigen Therapeutics Gains Extension To Regain Compliance With Minimum Bid Price Requirement
Brief: Qualigen Therapeutics announces formation and first meeting of QN-302 Scientific Advisory Board
Brief: Qualigen Therapeutics Inc Reports Second Quarter 2022 Financial Results And Provides Corporate Update
Brief: Qualigen Therapeutics Inc Files For Mixed Shelf Of Up To $150 Million – SEC Filing
Brief: Qualigen Therapeutics Announces Partnership With Hande Sciences To Scale-Up Manufacturing To Support IND-Enabling Studies For QN-302
Brief: Qualigen Therapeutics Files Prospectus Related To Proposed Resale From Time To Time Of Up To 8.2 Million Shares By Selling Stockholders
Brief: Qualigen Therapeutics Acquires Majority Stake In Infectious Disease Diagnostics Technology Company Nanosynex
Brief: Qualigen Therapeutics Provides Corporate Update, Reports First Quarter 2022 Financial Results
Brief: Qualigen Therapeutics To Acquire Majority Stake In Diagnostics Technology Company Nanosynex